We are live on
!
Find out more
MVP
Miller Value Partners Portfolio holdings
AUM
$423M
1-Year Est. Return
49.14%
This Fund
S&P 500
This Quarter
Est. Return
+4.8%
1 Year Est. Return
+49.14%
3 Year Est. Return
+132.73%
5 Year Est. Return
+100.12%
10 Year Est. Return
+859.21%
AUM
$2.63B
AUM Growth
+$104M
(+4.1%)
Cap. Flow
-$31.6M
Cap. Flow
% of AUM
-1.2%
Top 10 Holdings %
Top 10 Hldgs %
37.7%
Holding
117
New
15
Increased
33
Reduced
29
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TVTY
Tivity Health, Inc. Common Stock
TVTY
|
+$52M |
| 2 |
CVS Health
CVS
|
+$40.9M |
| 3 |
Alibaba
BABA
|
+$39.1M |
| 4 |
ADT
ADT
|
+$30.9M |
| 5 |
EB
Eventbrite
EB
|
+$30.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lumen
LUMN
|
+$42.2M |
| 2 |
AGN
Allergan plc
AGN
|
+$40.8M |
| 3 |
CELG
Celgene Corp
CELG
|
+$39.9M |
| 4 |
AVP
Avon Products, Inc.
AVP
|
+$26.7M |
| 5 |
EIGI
Endurance International Group Holdings, Inc.
EIGI
|
+$25.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.76% |
| 2 | Financials | 19.36% |
| 3 | Consumer Discretionary | 18.02% |
| 4 | Industrials | 11.94% |
| 5 | Communication Services | 10.05% |
Similar funds
WPC
ACM
BA
WTFG
MWP
MAMA
MI
AFWM
Miller Value Partners's Q2 2019 Portfolio in Review
As of Q2 2019, Miller Value Partners held 117 positions worth $2.63B, up 4.1% from $2.52B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Miller Value Partners's Q2 2019 filing shows 15 new, 33 increased, 29 reduced and 15 closed positions. Its largest new stake was Tivity Health, Inc. Common Stock: 2,693,150 shares worth $44.3M. The largest sale was Lumen, an estimated $42.2M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 24% a quarter earlier, followed by Financials and Consumer Discretionary.
- Miller Value Partners's largest Q2 2019 buy was Tivity Health, Inc. Common Stock: 2,693,150 shares worth $44.3M.
- Miller Value Partners added most to Alibaba in Q2 2019, an estimated $39.1M increase.
- Miller Value Partners's biggest Q2 2019 reduction was Lumen, cutting an estimated $42.2M.
- Miller Value Partners fully exited Allergan plc in Q2 2019, selling an estimated $40.8M.
- Miller Value Partners's ten largest holdings make up 38% of its $2.63B portfolio in Q2 2019.
- Miller Value Partners opened 15 new positions and closed 15 in Q2 2019.
- Miller Value Partners's portfolio value rose 4.1% quarter-over-quarter to $2.63B.
Based on Miller Value Partners's 13F filing for Q2 2019, filed 14 Aug 2019.